GLP-1 receptor agonists are licensed in the UK for type 2 diabetes mellitus and specific weight management indications, not for cognitive impairment or dementia GLP-1 receptors are present in brain regions involved in memory and learning, prompting research into potential neuroprotective effects Ongoing clinical trials, including studies of semaglutide in Alzheimer's disease, are examining whether these medications benefit cognitive function Common adverse effects include gastrointestinal symptoms
Easy process This product has proven highly effective in facilitating healthy weight loss without any reported side effects
Substantial clinical research base, growing research adoption
Consider keeping a simple food and symptom log to identify your personal tolerance threshold
However, as with any supplement, if you have pre-existing medical conditions, are pregnant or breastfeeding, or are taking other medications, we always recommend consulting with your healthcare professional before incorporating any new supplement into your regimen